Three things to know:
1. Based on Sirakoss’ proprietary nano-porous technology, Osteo3 consists of an inorganic matrix designed to be completely reabsorbed into the bone.
2. Osteo3 is intended for use as a bone graft material for filling skeletal system voids or gaps. It can be used alone or in combination with autograft or allograft.
3. Sirakoss is a nano-synthetic bone graft substitute developer.
More articles on biologics:
CollPlant names new board chairman: 4 insights
Ortho RTi releases results of 2 regenerative medicine studies
California neuroscience institute joins regenerative medicine clinical trial: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
